Sintx Technologies Inc. logo

Sintx Technologies Inc. (0A8S)

Market Closed
12 Jun, 15:30
LSE LSE
$
2. 13
0
0%
$
- Market Cap
- P/E Ratio
- Div Yield
467 Volume
-3.67 Eps
$ 2.13
Previous Close
Add Transaction
Day Range
2.06 2.29
Year Range
1.85 7.1
Want to track 0A8S and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

0A8S closed Friday higher at $2.13, an increase of 0% from Thursday's close, completing a monthly decrease of -2.7397% or -$0.06. Over the past 12 months, 0A8S stock lost -43.2%.
0A8S is not paying dividends to its shareholders.
The last earnings report, released on May 11, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.3667%, based on the last three reports.
Sintx Technologies Inc. has completed 2 stock splits, with the recent split occurring on May 28, 2024.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on NASDAQ (CM) (USD).

0A8S Chart

Sintx Technologies Inc. (0A8S) FAQ

What is the stock price today?

The current price is $2.13.

On which exchange is it traded?

Sintx Technologies Inc. is listed on LSE.

What is its stock symbol?

The ticker symbol is 0A8S.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Sintx Technologies Inc. ever had a stock split?

Sintx Technologies Inc. had 2 splits and the recent split was on May 28, 2024.

Sintx Technologies Inc. Profile

Technology Hardware, Storage & Peripherals Industry
Information Technology Sector
Eric K. Olson CEO
LSE Exchange
US8293927039 ISIN
US Country
20 Employees
29 Jul 2019 Last Dividend
20 Dec 2022 Last Split
13 Feb 2014 IPO Date

Overview

Sintx Technologies, Inc. is a pioneering advanced materials company focused on the research, development, and commercialization of medical devices made from silicon nitride. The company actively works on applications spanning biomedical, industrial, and antipathogenic fields within the United States. Originally known as Amedica Corporation, Sintx Technologies has rebranded itself while maintaining its commitment to innovation in materials science. Founded in 1996, the company's headquarters are strategically located in Salt Lake City, Utah, a hub for biomedical research and development.

Products and Services

  • Solid and Porous Silicon Nitride:

    These are core products that utilize silicon nitride's unique properties, such as its resistance to bacteria and its ability to promote bone growth. These characteristics make it suitable for various medical implants and devices.

  • Silicon Nitrite Powder:

    This product is crucial for manufacturers seeking the mechanical and chemical properties of silicon nitride in a versatile powder form. It's widely used in industrial applications and the development of antipathogenic surfaces.

  • Silicon Nitride Coating Products:

    These coatings leverage silicon nitride's biocompatibility and resistance to wear and corrosion, making them ideal for enhancing the longevity and performance of medical devices and industrial components.

  • Silicon Nitride Composite Materials:

    Composite materials blend silicon nitride with other substances to achieve specific performance objectives, such as improved strength or durability, for both industrial and medical applications.

  • Polyetherketoneketone:

    This offering indicates Sintx's diversification into high-performance thermoplastics, known for their chemical resistance and mechanical properties, suitable for demanding environments in various industrial applications.

Contact Information

Address: 1885 West 2100 South
Phone: 801 839 3500